Skip to search formSkip to main contentSkip to account menu

Crestor

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
When Lipitor, an anti-cholesterol drug (statin) of Pfizer, hit the market in 1997, Pfizer did not establish any direct evidence… 
2015
2015
The patient is a 75-year-old housewife, who underwent menopause about 20 years ago. She has a long-standing history of back and… 
2015
2015
  • S. Wolfe
  • BMJ : British Medical Journal
  • 2015
  • Corpus ID: 30804985
More is spent in the US on rosuvastatin than any other statin. Yet the evidence of its health benefits has always been weak and… 
2014
2014
The research on patient compliance and efficiency of the use of statins for initial and secondary prevention of cardio-vascular… 
2012
2012
OBJECTIVE To evaluate the effects of domestic rosuvastatin tablets on coronary plaque in the patients with mild-to-moderate… 
2008
2008
  • C. Harrison
  • Nature Reviews Drug Discovery
  • 2008
  • Corpus ID: 38080507
actions against seven generics manufacturers — Aurobindo, Apotex, Cobalt, Par, Sandoz, Mylan and Sun — who have submitted… 
2004
2004
  • E. Wooltorton
  • Canadian Medical Association Journal
  • 2004
  • Corpus ID: 46171246
Reason for posting: Rosuvastatin (Crestor) is a relatively new cholesterol-lowering drug that has become one of the top-selling… 
Review
2004
Review
2004
  • A. Scheen
  • Revue medicale de Liege
  • 2004
  • Corpus ID: 22370684
Rosuvastatin (Crestor) has been recently launched in Belgium by AstraZeneca. This new statin is indicated for the treatment of… 
2004
2004
  • S. Frantz
  • Nature Reviews Drug Discovery
  • 2004
  • Corpus ID: 1997598
If primary endpoint data for cancer treatments aren't met, positive secondary endpoint data will not guarantee approval, says the…